| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -115.8% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 4.4 | n/a |
| Pr/Book | 0.9 |
| Latest | F'cast | |
|---|---|---|
| Revenue | -22.6% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 0.39 | (2.38) | (2.90)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-21 | 1.26 | (2.92) | (13.20)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 1.82 | (3.71) | (13.90)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | 3.78 | (2.90) | (11.20)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | 2.92 | (3.73) | (12.60)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Interim Results and Investor Presentation | 30-Sep-2025 | 07:00 | RNS |
| Asset Purchase Agreement with Destiny Pharma | 22-Sep-2025 | 07:00 | RNS |
| Notice of Interim Results | 18-Sep-2025 | 07:00 | RNS |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 46.11p |
| Change Today | 0.11p |
| % Change | 0.24 % |
| 52 Week High | 56.50 |
| 52 Week Low | 36.50 |
| Volume | 261,032 |
| Shares Issued | 27.77m |
| Market Cap | £12.80m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 11:00 | 543 @ 47.00p |
| 11:00 | 307 @ 47.00p |
| 11:00 | 236 @ 47.00p |
| 10:53 | 1,689 @ 45.12p |
| 10:50 | 128,000 @ 46.03p |
You are here: research